This is the text extract for September Tender Results, browse documents here.

---

30 September 2009

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept and decline tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 21 December 2007 and Invitation to Tender dated 23 December 2008. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 12th October 2009. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. 2007/08 Tender Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 21 December 2007.

The decisions were as follows:

Chemical Name Clindamycin Dihydrocodeine Tartrate Docusate Sodium with Sennosides Ethinyloestradiol with Levonorgestrel Gelatin Plasma Replacer Ibuprofen Ibuprofen Ibuprofen Iron Sucrose* Minocycline Hydrochloride Minocycline Hydrochloride Phenobarbitone Sodium Tranexamic Acid

Line Item Cap hydrochloride 150 mg Tab long-acting 60 mg Tab 50 mg with total sennosides 8 mg Tab ethinyloestradiol 30 mcg with levongestrel 50 mcg (6) and ethinyloestradiol 40 mcg with levonorgestrel 75 mcg (5), and ethinyloestradiol 30 mcg with levonorgestrel 125 mcg (10) and 7 inert tab Inf 4% 500 ml bag Tab 400 mg Tab 600 mg Tab long-acting 800 mg Inj 20 mg per ml Cap 100 mg Tab 50 mg Inj 200 mg per ml, 1 ml Tab 500 mg

* This tender decline was for the community market only.

A303184 - qA12214

---

2008/09 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 October 2009, reference pricing of nontender winning brand will occur on 1 December 2009 and Sole Subsidised Supply commences on 1 March 2010.

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Tab EC 25 mg; 50 tablets, blister

Current subsidy $3.51 (for 100 tablets) $25.88 (for 500 tablets)

New tender subsidy $1.63

Sole supply brand (Supplier) Diclohexal (Sandoz) Diclohexal (Sandoz)

Brands affected by reference pricing and delisting Apo-Diclo (Apotex) Apo-Diclo (Apotex)

Diclofenac sodium

Diclofenac sodium

Tab EC 50 mg; 50 tablets, blister

$2.13

2. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 November 2009, reference pricing of nontender winning brand will occur on 1 January 2010 and Sole Subsidised Supply commences on 1 April 2010.

The decisions were as follows:

Chemical Name Amoxycillin clavulanate Amoxycillin clavulanate

Presentation; Pack size and type Grans for oral liq 125 mg with potassium clavulanate 31.25 mg per 5 ml; 100 ml, bottle

Current subsidy $2.75

New tender subsidy $2.20

Sole supply brand (Supplier) Curam (Sandoz)

Brands affected by reference pricing and delisting Augmentin (GSK)

Grans for oral liq 250 mg with potassium clavulanate 62.5 mg per 5 ml; 100 ml, bottle Cyproterone acetate Tab 2 mg with ethinyloestradiol 35 µg with ethinyloestradiol and 7 inert tabs; 84 tablets; blister Metformin Tab immediate-release 500 mg; 500 hydrochloride tablets, bottle Metformin Tab immediate-release 850 mg; 250 hydrochloride tablets, bottle Mometasone furoate Mometasone furoate Mometasone furoate Mometasone furoate Crm 0.1%; 15 g OP, tube Crm 0.1%; 45 g OP, tube Oint 0.1%; 15 g OP, tube Oint 0.1%; 45 g OP, tube

$4.75 $6.30 $9.75 $8.00 $3.96 $10.82 $3.96 $10.82

$3.85 $4.91 $8.09 $6.67 $2.38 $4.55 $2.38 $4.55

Curam (Sandoz) Ginet 84 (Rex) Apotex (Apotex) Apotex (Apotex) m-Mometasone (Multichem) m-Mometasone (Multichem) m-Mometasone (Multichem) m-Mometasone (Multichem)

Augmentin (GSK) Estelle 35 ED (Douglas) Arrow-Metformin (Arrow) Arrow-Metformin (Arrow) Elocon (Schering-Plough) Elocon (Schering-Plough) Elocon (Schering-Plough) Elocon (Schering-Plough)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 3. Tenders awarded to listed pharmaceuticals where only the current brand is listed – price changes (where applicable) for hospital tender winning brands of the pharmaceuticals will occur in Section H of the Pharmaceutical Schedule on 1 November 2009; DV Limits and DV Pharmaceuticals will apply from 1 January 2010.

A303184 - qA12214 Page 2 of 4

---

The decisions were as follows:

Chemical Name Idarubicin hydrochloride Idarubicin hydrochloride Idarubicin hydrochloride Idarubicin hydrochloride

Presentation; Pack size and type Cap 5 mg; 1 capsule, blister Cap 10 mg, 1 capsule, blister Inj 5 mg, 1 injection, vial Inj 10 mg, 1 injection, vial

Hospital Supply Brand (Supplier) Zavedos (Pfizer) Zavedos (Pfizer) Zavedos (Pfizer) Zavedos (Pfizer)

Pack Price $115.00 $144.50 $170.00 $340.00

DV Limit 1% 1% 1% 1%

DV Pharmaceuticals Brand Name (Supplier) (B) (B) (B) (B)

4. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – listing for hospital tender winning brands of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 November 2009; DV Limits and DV pharmaceuticals will apply from 1 January 2010; de-listing of other brands in Section H will occur on 1 January 2010.

Presentation; Pack size and type Hospital Supply Brand (Supplier) Pack Price DV Limit DV Pharmaceuticals Brand Name (Supplier) Alpha-Amoxyclav (Apotex) Augmentin (GSK) Synermox (Douglas) Grans for oral liq 250 mg with Amoxycillin clavulanate potassium clavulanate 62.5 mg per 5 ml; 100 ml, bottle Alpha-Amoxyclav (Apotex) Augmentin (GSK) Synermox (Douglas) Amoxycillin clavulanate Amoxycillin clavulanate Inj 600 mg; 10 injections, vial Inj 1.2 g; 10 injections, vial Curam (Sandoz) Curam (Sandoz) $12.67 $16.50 1% 1% Augmentin (GSK) Synermox (Douglas) Augmentin (GSK) Synermox (Douglas) 3M Metformin (Douglas) Metformin hydrochloride Tab immediate-release 500 mg; 500 tablets, bottle Apotex (Apotex) $8.09 1% Arrow-Metformin (Arrow) Glucomet (Douglas) Metomin (Mylan) 3M Metformin (Douglas) Metformin hydrochloride Tab immediate-release 850 mg; 250 tablets, bottle Apotex (Apotex) $6.67 1% Arrow-Metformin (Arrow) Glucomet (Douglas) m-Mometasone (Multichem) m-Mometasone (Multichem) m-Mometasone (Multichem) m-Mometasone (Multichem) Oxaliplatin Ebewe (InterPharma) Metomin (Mylan) Elocon (Schering-Plough) Elocon (Schering-Plough) Elocon (Schering-Plough) Elocon (Schering-Plough) Hospira (Hospira)

Chemical Name

Grans for oral liq 125 mg with Amoxycillin clavulanate potassium clavulanate 31.25 mg per 5 ml; 100 ml, bottle

Curam (Sandoz)

$2.20

1%

Curam (Sandoz)

$3.85

1%

Mometasone furoate Mometasone furoate Mometasone furoate Mometasone furoate Oxaliplatin*

Crm 0.1%; 15 g, tube Crm 0.1%; 45 g, tube Oint 0.1%; 15 g, tube Oint 0.1%; 45 g, tube Inj 50 mg; 1 injection, vial

$2.38 $4.55 $2.38 $4.55 $65.00

1% 1% 1% 1% 1%

A303184 - qA12214

Page 3 of 4

---

Chemical Name

Presentation; Pack size and type

Hospital Supply Brand (Supplier)

Pack Price

DV Limit

DV Pharmaceuticals Brand Name (Supplier) Eloxatin (Sanofi-Aventis) Oxaliplatin Dakota (Sanofi-Aventis) Oxaliplatin Winthrop (Sanofi-Aventis) Hospira (Hospira) Eloxatin (SanofiAventis)

Oxaliplatin*

inj 100 mg; 1 injection, vial

Oxaliplatin Ebewe (InterPharma)

$130.00

1%

Oxaliplatin Dakota (Sanofi-Aventis)

Oxaliplatin Winthrop (Sanofi-Aventis) *Please note Oxaliplatin Ebewe will also be listed in Section B of the Pharmaceutical Schedule for PCT and the ECP price for oxaliplatin will be amended accordingly, from 1 January 2010.

Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 23 December 2008.

The decisions were as follows:

Chemical Name Dantrolene Sodium Metaraminol Tartrate Nicotinic Acid Rocuronium

Line Item Inj 1 mg per ml, 20 ml Inj 10 mg per ml, 1 ml Tab 500 mg Inj 10 mg per ml, 10 ml

For the remaining products on the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 23 December 2008 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A303184 - qA12214

Page 4 of 4